Apparatus and method for detecting disconnection of an intravascular access device

Information

  • Patent Grant
  • 10201650
  • Patent Number
    10,201,650
  • Date Filed
    Thursday, October 23, 2014
    9 years ago
  • Date Issued
    Tuesday, February 12, 2019
    5 years ago
Abstract
An apparatus and method are disclosed for detecting the disconnection of a vascular access device such as a needle, cannula or catheter from a blood vessel or vascular graft segment. A pair of electrodes is placed in direct contact with fluid or blood in fluid communication with the vascular segment. In one embodiment, the electrodes are incorporated into a pair of connectors connecting arterial and venous catheters to arterial and venous tubes leading to and from an extracorporeal blood flow apparatus. Wires leading from the electrodes to a detecting circuit can be incorporated into a pair of double lumen arterial and venous tubes connecting the blood flow apparatus to the blood vessel or vascular graft. The detecting circuit is configured to provide a low-voltage alternating current signal to the electrodes to measure the electrical resistance between the electrodes, minimizing both the duration and amount of current being delivered. Detection of an increase in electrical resistance between the electrodes exceeding a pre-determined threshold value may be used to indicate a possible disconnection of the vascular access device.
Description
BACKGROUND

The present invention relates generally to systems and methods to detect disconnection of an indwelling vascular line, such as a catheter or needle, or its attached tubing. If not quickly detected, a disconnection can lead to rapid exsanguination, particularly when the blood in the catheter or tubing is under positive pressure. Examples of circumstances involving positive intravascular pressure include the positive pressure associated with an artery or arterio-venous fistula, or the positive pressure associated with an extracorporeal blood pump circuit. In hemodialysis, for example, a blood pump can generate blood flow rates of 400-500 ml/min, making rapid, reliable disconnect detection particularly desirable. Indeed any medical treatment involving relatively high flow or high pressure extracorporeal circulation (such as, for example, hemoperfusion or cardiopulmonary bypass) can be made safer by having an effective system to monitor the integrity of the arterial (withdrawal) and venous (return) blood lines.


In hemodialysis, for example, extracorporeal blood circulation can be accomplished with vascular access using either a single indwelling catheter, or two separate indwelling catheters. In a single catheter system, blood is alternately withdrawn from and returned to the body via the same cannula. A disconnection in this system can be quickly detected by placing an air monitor in the line at or near the pump inlet, because air will be drawn into the line from the disconnection site during the blood withdrawal phase of the pumping. On the other hand, in a two-catheter system, blood is typically continuously withdrawn from the body via one catheter inserted in a blood vessel or fistula, and returned to the body via the second catheter inserted in the same vessel some distance from the first catheter, or in a separate blood vessel altogether. In the two-catheter system, it is also possible to monitor for catheter or tubing dislodgement in the blood withdrawal or ‘arterial’ segment by using a sensor to detect the presence of air being entrained into the arterial tubing as blood is withdrawn from the blood vessel under negative pump pressure and/or positive fistula pressure. However, air-in-line detection cannot reliably detect a disconnection of the venous (return) segment of the extracorporeal circuit. In this case, if the blood-withdrawal path remains intact, air will not be introduced into the line. Thus it is particularly important to be able to detect a disruption in the continuity of the return line from the extracorporeal pump to the vascular access site.


Attempts have been made to develop systems to detect dislodgment based on the electrical, mechanical or acoustical properties of blood in the extracorporeal circuit. These systems have not been very effective because of the relatively high impedance of a blood circuit that includes long stretches of tubing, one or more blood pumps, valves, air traps and the like. Furthermore, the electrical interference generated by various devices along the blood path may obscure the signal that one is attempting to monitor.


An electrical signal can be introduced into the blood circuit through induction using a field coil surrounding a section of the blood tubing. It may also be introduced through capacitive coupling. For reasons of patient safety, the strength of an electrical signal introduced into the blood circuit necessarily must be small. However, the dielectric properties of the wall of the blood tubing can cause excessive noise or interference when attempting to detect conductivity changes in the blood from an electrical signal introduced through inductive or capacitive coupling. Therefore, it may be more desirable to introduce a brief, small electrical signal through direct contact with the blood path, to limit the length (and therefore impedance) of the blood path being monitored, and to perform the monitoring function at a suitable distance from any interference-producing components.


SUMMARY

In one aspect, the invention comprises a system for detecting whether a vascular access device, such as a needle, cannula, catheter, etc. becomes disconnected or dislodged from a blood vessel or vascular graft. The system includes a fluid delivery device that provides for the flow of a liquid through a tube or conduit into the blood vessel via an indwelling needle or catheter at a first site on the blood vessel or graft. The fluid may be an electrolyte solution or other solution suitable for intravenous infusion, or it may be blood or blood components. An electrode is disposed to be in contact or fluid communication with the lumen of the conduit, and a second electrode is disposed to be in fluid communication with blood within the blood vessel or graft via a second on the blood vessel or graft. An electronic circuit is connected to the first and second electrodes, and configured to deliver a control signal to the first and second electrodes in order to measure the electrical resistance of the fluid between the first and second electrodes, such that at least one of the electrodes is located closer to the blood vessel or graft than to the fluid delivery device. In some embodiments the electrode is located at about 50-70% of the distance from the fluid delivery device to the blood vessel or graft. In other embodiments, the electrode is located at about 70-90% or more of the distance from the fluid delivery device to the blood vessel or graft. The fluid delivery device can include a pump, either for blood or for other therapeutic or diagnostic fluid. The fluid delivery device can be part of a hemodialysis blood flow circuit, which may or may not include a blood pump, a dialyzer cartridge, or an air trap and associated tubing. The second electrode may be placed in contact with the lumen of a second conduit or tube that is in fluid communication with the blood vessel or graft at the second site. The second conduit may form part of a fluid flow path from the blood vessel or graft to the fluid delivery device. The fluid in the second conduit may be blood being delivered to an extracorporeal blood flow circuit.


The system may comprise a first and second connector connecting a pair of vascular access catheters accessing a blood vessel segment or vascular graft segment at two different sites. The first and second connectors may each connect to a flexible tube leading to the fluid delivery device. Each connector may include an electrode that is exposed to the lumen of the connector. A wire may be attached to each connector, the wire being connectable on its other end to the electronic circuit. The flexible tubes may be double lumen tubes having a first lumen for carrying fluid and a second lumen for carrying a wire. The wires of each tube may be connected on the other end of the tube to a connector for connection to the electronic circuit.


The electronic circuit or an associated microprocessor may be configured to convert the voltages measured across terminals connected to the electrodes by the electronic circuit into resistance values. The system may comprise a controller configured to receive a signal from the electronic circuit or microprocessor, the signal representing the electrical resistance between the electrodes, the controller being programmed to trigger an alert signal when the electrical resistance value exceeds a pre-determined threshold. The alert signal may be an audible or visual signal to the person whose blood vessel is being accessed, and optionally an alert signal may include an electrical command to a tubing occluder apparatus. The tubing occluder apparatus may be actuated to mechanically occlude one or more of the tubes leading from the vascular access sites. The tubing occluder may operate in a number of ways, such as, for example electromechanically, hydraulically, or pneumatically.


In another aspect, the invention comprises an apparatus for monitoring the continuity between a vascular access device and a blood vessel or vascular graft segment, comprising, a first and second vascular connector, the first connector being attached on a proximal end to a distal end of a fluid-carrying lumen of a first double-lumen tube, and the second connector being attached on a proximal end to a distal end of a fluid-carrying lumen of a second double-lumen tube. The first connector comprises a first electrode in contact with a lumen of the first connector and electrically connected to a wire within a wire-carrying lumen of the first double-lumen tube, and the second connector comprises a second electrode in contact with a lumen of the second connector and electrically connected to a wire within a wire-carrying lumen of the second double-lumen tube. The wire within the first double-lumen tube and the wire within the second double-lumen tube are each connected to an electrical connector at a proximal end of the double-lumen tubes. The distal end of each connector may be configured with a locking feature to provide a reversible, air-tight connection between the connector and a mating connector of a vascular catheter. The proximal end of the double-lumen tubes can be connected to a blood pump on an arterial side, and an air trap on a venous side; and in a hemodialysis system, the blood pump and air trap may each be reversibly connectable to a dialyzer cartridge.


In another aspect, the invention comprises a vascular connector comprising a proximal fluid connection end, a distal fluid connection end, and an electrode configured to electrically connect a fluid-carrying lumen of the connector with a wire external to the vascular connector. The proximal end of the connector may be configured to connect with a flexible tube, and the distal end of the connector may be configured to connect with a mating connector of a vascular catheter. The electrode may be installed in a conduit on the connector that connects the lumen of the connector to the exterior of the connector. The electrode may be lodged into the conduit in a manner to provide an air-tight seal between the lumen and the exterior of the connector. An elastomeric member such as an O-ring may be installed between the electrode and the conduit to contribute to the air-tight seal.


In another aspect, the invention comprises an electrical circuit for measuring the resistance of a liquid between a first and second electrode, the first electrode connected to a first terminal of the electrical circuit, and the second electrode connected to a second terminal of the electrical circuit, comprising a capacitor C1 connected on a first end to the first terminal and a capacitor C2 connected on a first end to the second terminal; a known reference resistance Rref connected on a first end to a second end of capacitor C1; switching means for connecting either (a) a first reference voltage V+ to a second end of Rref, and a lower second reference voltage V− to a second end of C2 to form a first switch configuration or; (b) the first reference voltage V+ to the second end of C2 and the lower second reference voltage V− to the second end of Rref to form a second switch configuration; and measuring means for measuring a voltage Vsense at the connection between C1 and Rref; such that the electrical circuit is configured to determine the value of the resistance of the liquid based on the known reference resistance Rref and the observed voltage Vsense for each of the first and second switch configurations. The resistance Rref may be chosen to be a value that permits conductivity measurement of an electrolyte solution or other solution suitable for intravenous infusion. The electrolyte solution may include dialysate solution. The resistance Rref may also be chosen to permit measurement of the resistance of a volume of blood between the first and second electrodes.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic representation of a conductivity circuit in an illustrative embodiment;



FIG. 2 is a diagram of the electrical waveforms processed by the circuit of FIG. 1;



FIG. 3 is a representative graph of the noise/error sensitivity of the circuit of FIG. 1 plotted against the ratio of unknown/reference resistance in the circuit;



FIG. 4 is a schematic representation of an exemplary blood flow circuit of a hemodialysis system;



FIG. 5A is a side view of a connector that may be used in the blood flow circuit of FIG. 4;



FIG. 5B is a cross-sectional view of the connector of FIG. 5A;



FIG. 6 is a cross-sectional view of the connector of FIGS. 5A and 5B, with an attached wire and flexible tubing;



FIG. 7A is a perspective view of an alternate embodiment of a connector that may be used in the blood flow circuit of FIG. 4;



FIG. 7B is a top view of the connector of FIG. 7A;



FIG. 7C is a cross-sectional view of the connector of FIG. 7B;



FIGS. 8A-D are various cross-sectional views of a flexible tube incorporating a conductive wire;



FIG. 9 is a perspective view of a flexible double-lumen tube having a fluid-carrying lumen and a wire-carrying lumen;



FIG. 10 is a cross-sectional view of a connector similar to the connector of FIGS. 7A-C, with an attached wire and tubing;



FIG. 11 is a plan view of an extracorporeal blood flow circuit used in a representative hemodialysis system;



FIG. 12 is a perspective view of a hemodialysis apparatus configured to receive and operate the extracorporeal blood flow circuit of FIG. 11;



FIG. 13 is a representative plot of the resistance measured by the conductivity circuit of FIG. 1 under various conditions.





DETAILED DESCRIPTION

Conductivity Circuit


An exemplary electrical circuit shown in FIG. 1 can be used to measure the electrical conductivity or resistance of a subject fluid. In one embodiment, the fluid may be an electrolyte solution or dialysate fluid, and the circuit may ultimately provide a measurement of the conductivity of the fluid to ensure its compatibility for intravascular administration. In addition to monitoring the concentration of dissolved solutes in the fluid, the electrical circuit can also monitor for any interruption in the continuity of the fluid between the electrodes connected to the circuit. For example, it can be used to monitor an intravenous fluid line for the presence of air bubbles, or for the presence of a contaminating substance. In another embodiment, the fluid may be blood, and a change in the measured electrical resistance of a blood flow path (for example, in a conduit) may be used to indicate if a discontinuity occurs between the blood flow path and measuring electrodes. For example, the blood flow path may comprise a column of blood between two electrodes that includes indwelling needles or catheters in a segment of a blood vessel, arterio-venous fistula or graft. Vascular access disconnection can result in the introduction of air into the blood flow path, causing a change in the resistivity of the blood column between the electrodes. The electrical circuit can be readily modified (depending on its application) to adjust for the difference between the impedance of a blood flow path and that of dialysate fluid.


The circuit shown in FIG. 1 may be used to measure an unknown resistance Rx of a subject media 1 using inexpensive electronic components, particularly where the unknown resistance involves a conductive path through an electrolytic fluid. A switching network 2 comprising a pair of multiplexers allows the connection of nodes VA and VB to reference voltages V+ and V−. The subject media 1 having unknown resistance Rx is connected to terminals VTA and VTB3, and forms a voltage divider with reference resistor Rref4. To make a conductivity measurement, alternating voltages can be presented to the subject media 1 via switching network 2 to the voltage divider created by the known reference resistor Rref4 (680 Ω, for example, in the case of dialysate fluid) and the unknown resistance RX of the subject media 1. The midpoint of the voltage divider 5 is measured. The signal VSense at point 5 is buffered by amplifier 10 to make the input signal Vin of the analog-to-digital converter (ADC) 11. VSense switches between two values as the voltage divider is driven first one way and then the other way. This signal is valid only for a short period of time after switching because the fluid in the conductivity cell 1 is AC coupled into the circuit through capacitors C1 and C26. Thus DC-blocking capacitors C1 and C26 may be used to prevent DC currents from passing through the unknown resistance (which may include a conductive path through electrolytic fluid or blood). In an embodiment, series capacitors C can each comprise two capacitors in parallel, one having a value, e.g., of 0.1 uF, and the other having a value, e.g., of 10 uF. Series resistors 7 may be used to reduce exposure by the switch network and other sense circuitry to noise and surge voltages. ADC 11 can take multiple samples of the signal as the circuit is switched between the two configurations.


The switching network 2 can be driven by a pair of alternating binary control signals 13, 14 that connect VA to V+ and VB to V− during one half-cycle, and VB to V+ and VA to V− during the other half-cycle. This results in a waveform at the Vsense node 5 that is similar to the waveform 20 shown in FIG. 2. In this embodiment, Vref is 4 volts, resulting in a Vsense amplitude of less than 4 volts, as shown in FIG. 2. A voltage divider 8 creates the voltages V+ and V− that are near the positive reference voltage VRef and near ground, respectively. In one embodiment, R1 can have a value of 10 ohms, and R2 can have a value of 2K ohms When both multiplexers of switching network 2 are commanded to zero, the circuit is at rest and the lower voltage is presented to terminals VTA and VTB 3. When VA is high and VB is low, the higher voltage is presented to the reference resistor RRef 4 and the lower voltage is presented to the subject media 1 having unknown resistance Rx. When VB is high and VA is low, the higher voltage is presented to the subject media 1 having unknown resistance Rx and the lower voltage is presented to the reference resistor RRef 4.


A change in voltage ΔVsense before and after each square wave edge, can be shown to depend only on the reference resistance Rref4, the unknown resistance Rx of subject media 1, and any series resistance (including, e.g., Rs 7), and is generally independent of series capacitance C1 or C26, since during this short time period the capacitor acts as an incremental short circuit. In particular,

Δα=ΔVsense/(V+−V)=(Ry−Rref−Rth)/(Ry+Rref+Rth)=(ρ−1)/(ρ+1)

where Ry=Rx+2Rs+Rth, where Rth=source series resistance from multiplexer 2 and voltage divider 8, and ρ=Ry/(Rref+Rth). (Source series resistance Rth can be derived as the sum of the resistance of multiplexer 2 and the Thevenin equivalent resistance of the voltage divider 8. For example, for R1=10 ohms, R2=2K ohms, then Rth=R1∥(R1+R2)=9.95 ohms). Thus, if Ry is a short circuit, then ρ=∞and Δα=−1. The sense node's change in voltage ΔVsense is then equal to the voltage change at VB which has an amplitude opposite to the drive node at VA. If Ry is an open circuit, then ρ=∞ and Δα=1. The sense node's change in voltage is then equal to the voltage change at the drive node VA. Accordingly, if this change in voltage is measured, the preceding equations can be solved for the unknown resistance Rx:

Rx=ρ(Rref+Rth)−2Rs−Rth,

where ρ=(1+Δα)/(1−Δα)


As shown in FIG. 1, a low-pass filter 9 can be formed by resistor Rf and capacitor Cf, to filter out high-frequency noise. In one exemplary arrangement, RF can have a value of 1K Ω, and CF can have a value of 0.001 uF. Buffer amplifier 10 and analog-to-digital converter (ADC) 11 can then measure the sensed voltage for a computer or digital signal processor (not shown).


The reference voltages V+ and V− may be advantageously derived from a voltage divider 8 so that V+ is close to the reference voltage VRef of the ADC 11, and V− is close to the ground reference voltage of the ADC 11. For example, for R1=10Ω, R2=2 kΩ, and Vref=4.0V, then V+=3.980V, and V−=0.020V. This places both voltages within but near the edges of the active sensing region of the ADC 11, where they can be used for calibration (discussed below). Switch SW1 12 may be used to help calibrate the load resistance sensing.


Several improvements may decrease errors related to variations of component values. First, a calibration step can be introduced where VA is switched to V+ for a relatively long period of time, until Vsense settles and is approximately equal to V+, at which point ADC 11 can take a measurement of Vsense. A second calibration step can involve switching VA to V− for a relatively long period of time, until Vsense settles and is approximately equal to V−, at which point ADC 11 can take another measurement of Vsense. This allows the ADC 11 to measure both V+ and V−.


Secondly, as shown in FIG. 2, while the square wave is switching, ADC 11 readings before and after both edges of the switching waveform may be used to compute the dimensionless quantity Δα:

Δα=ΔVSense/(V+−V−)=[(V2−V1)+(V3−V4)]/2(V+−V−)

As a result, both edges of the waveform can be used to measure


ΔVSense=[(V2−V1)+(V3−V4)]/2, so that asymmetric responses to the circuit are likely to be canceled out. Alternatively, an average voltage at about the midpoint of the waveform may be used; so that, for example, Δα=ΔVSense/(V+−V−)=[(V7−V6)+(V7−V8)]/2(V+−V−), and ΔVSense=[(V7−V6)+(V7−V8)]/2. In addition, only differential measurements of the input signal Vin of the ADC 11 can be used. Thus, any offset errors of the buffer amplifier 10 and ADC 11 can be canceled out. Also, Δα is a ratiometric quantity based on measurements using the same signal path. Thus, any gain errors of the ADC 11 can also be canceled out.


The reference resistor RRef 4 may be optimally chosen to be equal to the geometric mean of the endpoints of the desired range of unknown resistances, taking series resistances Rs 7 into account. For example, if Rs=100Ω and Rx varies from 100Ω to 3000Ω, then Ry=Rx+2Rs varies from 300Ω to 3200Ω, and Rref should be approximately the square root of (300 Ω·3200Ω)=980Ω. To measure an unknown resistance in the range of 100 k-300 k ohms (as in, for example, a column of blood extending from one electrode to another via an arterio-venous fistula), the reference resistor Rref 4 can be changed to approximately 200 k ohms and the filter capacitor RF of low pass filter 9 at the input to the buffering amplifier 10 can be removed completely.


Because a voltage divider's output is a nonlinear function of its resistance ratio, errors or noise in readings from the ADC 11 produce their lowest fractional error (sensitivity) in the resultant calculation of Ry when it is equal to Rref, and the sensitivity increases the more Ry diverges from the reference resistance Rref. Specifically, it can be shown that the sensitivity in resistance ratio is as follows:

Sρ=(1/ρ)·δρ/δΔα=2/[(1+Δα)(1−Δα)]=2/[1−(Δα)2]

When Ry=Rref, ρ=1, Δα=0 and Sρ=2. Thus, for a change in Δα of 0.001 (0.1% of the ADC full-scale) around this point, the calculated resistance Ry changes by 0.002 or 0.2%. The sensitivity increases as ρ diverges from 1, as shown in Table 1.











TABLE 1





ρ
Δα
Sρ

















1
0
2


2, 0.5
±0.333
2.25


4, 0.25
±0.6
3.13


5.83, 0.172
±0.707
4


10, 0.1
±0.818
6.05


20, 0.05
±0.905
11.03










FIG. 3 shows that the noise/error sensitivity doubles at about a 6:1 ratio of unknown/reference resistance, and triples at a 10:1 ratio. Resistance measurements outside this range may suffer in their increased sensitivity to noise and error.


For calibration purposes, a switch SW1 12 can be used to make resistance measurements to calibrate out a point at Rx=0. Preferably this switch 12 should be placed across the terminals VTA and VTB 3, or as close to the terminals as feasible, which would give a true zero-point calibration. In practice, however, locating the switch 12 close to the terminals VTA and VTB 3 may make the switch 12 prone to external noise and surge voltages, and may introduce DC leakage current into the subject media 1.


The series capacitances C1 and C26, and the use of square waves are important for unknown resistances that include an electrolytic conductive path. There are at least two reasons for this. First, it may be important in many applications to prevent DC current from flowing through an electrolyte solution or a bodily fluid having similar properties; otherwise electroplating and/or electrolysis of electrodes at the terminals VTA and VTB 3 can occur. In this circuit, the capacitors C1 and C26 block DC currents. Furthermore, because the capacitors may allow very small currents to flow (microamps or less), using an alternating square wave voltage may help to limit the average current further.


Secondly, in the event that a small electrochemical DC voltage is induced in the subject media 1 (for example, the electrodes in a fluid path may oxidize over time at different rates), this DC voltage can be blocked by the capacitors C1 and C26. Because the method for calculating resistance takes differential measurements, any residual DC voltage may be canceled out through the process of calculating the unknown resistance Rx of subject media 1.


Vascular Disconnect Detector


With the appropriate modifications of a conductivity measurement circuit such as the one described above, it is possible to detect the conductivity and changes in the conductivity of blood. More specifically, it is possible to detect the change that occurs in the conductivity of a volume of blood when air enters the volume. This situation can occur, for example, when an intravascular access site becomes dislodged in an extracorporeal blood circuit.


The circuit shown in FIG. 1 can be used to measure the resistance of a volume of fluid in a conductivity cell or conduit 1. For measurements of Rx of a conductivity cell 1 representing the resistance or conductivity of a volume of dialysate solution, a convenient value for the reference resistor RRef 4 can be chosen to be approximately 680 ohms. For measurements of Rx of a conduit 1 representing the resistance or conductivity of a column of blood extending from a first cannula or needle, through an arterio-venous fistula, to a second cannula or needle, a convenient value for the reference resistor RRef 4 can be chosen to be approximately 200 k ohms.


The advantages of using this circuit to monitor the continuity of a column of a bodily fluid such as blood or plasma include the following:

    • Capacitive coupling to the conductivity cell or conduit 1 blocks DC current which could cause plating and corrosion of electrodes at terminals VTA and VTB;
    • Voltages and current levels are very low and decoupled for patient safety;
    • Current only flows briefly while the measurement is being taken. No current flows between measurements.


With the lower reference resistor Rref 4 value (e.g. 680 ohms), this circuit is appropriately configured for dialysate conductivity measurements. With a much higher reference resistor Rref 4 value (e.g. 200 k ohms) this circuit is appropriately configured for measuring the resistance between an arterial needle and a venous needle to detect vascular needle dislodgement from an arterio-venous fistula.


Electrode Placement


The continuity of a fluid column leading from a fluid delivery apparatus to a patient's blood vessel or vascular graft can be monitored using the electronic circuit described above. The fluid being delivered may include blood or any electrolyte solution, including dialysate fluid. Although the following discussion will involve a hemodialysis system, the same principles of operation of the invention can apply to any device that is configured to deliver a fluid to a patient via a vascular access. In an embodiment illustrated by FIG. 4, the conductivity of a volume of blood or other fluid within a fluid flow circuit 100 of a hemodialysis machine 200 can be monitored electronically, using electrodes on each end of the volume that make direct contact with the blood or other fluid. Using an electrical circuit such as the one shown in FIG. 1, one electrode can be connected to the VTA terminal, and the other electrode can be connected to the VTB terminal of the circuit. The voltages applied to the electrodes by the circuit can be sufficiently small (e.g., about 4 volts or less), sufficiently brief, and with DC voltages sufficiently decoupled so as to prevent any harm to the patient. In this example, a fluid flow circuit 100 is shown, including an arterial access needle 102, an arterial catheter tubing 104, an arterial catheter tubing connector 106, arterial blood circuit tubing 108, a transition 110 between the blood circuit tubing 108 and hemodialysis machine 200, a blood pump inlet line 112, a blood pump 114, a blood pump outlet line 116, a dialyzer 118, a dialyzer outlet line 120, air trap 122, a transition 124 between hemodialysis machine 200 and venous blood circuit tubing 126, a venous catheter tubing connector 128, a venous catheter tubing 130, a venous access needle 132, and the intraluminal volume of that portion of the patient's blood vessel or fistula 134 that lies between the arterial access needle 102, and the venous access needle 132. It should be noted that the invention described herein also encompasses circumstances in which the arterial access needle may reside in one blood vessel of a patient, while the venous access needle may reside in a separate blood vessel some distance away from the arterial access site. Furthermore, the circuit described above may be used to monitor the integrity of a vascular access in a fluid delivery system that does not have the venous return line shown in FIG. 4. In that case, for example, an electrode at location B could be paired with an electrode in contact with fluid in a dead-end line communicating with a second needle or cannula accessing the blood vessel or vascular graft. In another example, an indwelling hollow cannula or solid trocar in the vascular segment can be equipped with a conductive wire which could then serve as the second electrode in the monitoring system. The vascular segment being accessed may be a surgically constructed arterio-venous fistula, and may also include an artificial conduit such as a Gortex vascular graft. The term ‘arterial’ is used herein to denote the portion of the blood flow circuit that conducts blood away from the patient and toward the hemodialysis machine 200. The term ‘venous’ is used to denote the portion of the blood flow circuit that conducts blood away from the hemodialysis machine 200 and back toward the patient. The term ‘access needle’ is used to denote a needle or catheter device that penetrates the patient's vascular segment or fistula. In different embodiments it may be permanently fused or reversibly connected to a corresponding catheter tubing 104, 130.


The continuity of any segment of the fluid flow circuit 100 can be monitored by positioning two electrodes in contact with the fluid on either side of the fluid and blood-containing segment of interest. In order to monitor for a disconnection of the arterial access needle 102, or the arterial catheter tubing 104, or the venous access needle 132 or venous catheter tubing 130, one electrode can be placed in continuity with the lumen of the venous side of the blood flow circuit, while a second electrode is placed in continuity with the lumen of the arterial side of the blood flow circuit. In one embodiment, the two electrodes can be positioned on or near the dialysis machine 200, with an electrode in contact with blood upstream of blood pump 110, and a second electrode in contact with blood downstream of the dialyzer 118 and/or air trap 122. For example, the electrodes can be incorporated into transition locations 110 and 124.


In another embodiment, one of the electrodes can be positioned to be in contact with the fluid in the fluid flow circuit 100 at a point that is closer to the vascular access site 134 than it is to the equipment (e.g. a dialysis machine) used to deliver fluid flow to the accessed blood vessel or vascular graft. In a preferred embodiment, both electrodes can be positioned to be nearer to the patient's blood vessel or vascular graft than the equipment associated with the dialysis machine 200. This may further reduce electrical interference associated with the dialysis machine 200. An electrode A can be conveniently placed at or near the arterial catheter tubing connector 106 and a second electrode B can be conveniently placed at or near the venous catheter tubing connector 128. In this arrangement, the electrical continuity pathway from the first electrode through the patient's vascular access to the second electrode is much shorter—and the electrical resistance lower—than the pathway extending back toward the dialysis machine 200. In some cases, the access catheters 104 and 130 can be as short as about a foot, whereas the arterial and venous tubings 108 and 126 can be about six feet long. Because of the electrical conductive properties of the fluid in the circuit, the electrical resistance associated with the pathway incorporating tubing 108 and 126, and components of the dialysis machine 200, can be many times greater than the electrical resistance associated with the pathway through the patient's blood vessel or fistula 134.


Electrical interference associated with the dialysis machine 200 is thus reduced, and a change in electrical resistance due to an access-related disconnection can more easily be detected. Preferably, the electrodes A and B are positioned to be more than 50% of the distance from the dialysis machine to the patient. More preferably (and more conveniently), the electrodes A and B are located near the last disengageable fluid connection before reaching the patient. In one embodiment of a hemodialysis system, the blood tubing 108 and 126 is approximately 6 feet in length, and the arterial and venous catheter tubes 104, 130 are about two feet or less in length. A convenient location for electrodes A and B would then be at the arterial line and venous line connectors 106, 128 (which can be, e.g. Luer type connectors or modifications thereof) that connect the arterial and venous blood circuit tubes 108, 126 with the arterial and venous catheter tubes 104, 130.


Connector Electrodes


As shown in FIGS. 5A and 5B, in one embodiment, a blood line connector for the blood circuit of a hemodialysis system may incorporate electrodes that can make contact with any liquid within the lumen of the connector. In one aspect, the electrode can comprise an annular conductive cap 310 placed at the tube-connection or proximal end 302 of any suitable connector, such as, for example connector 300. The electrode is preferably constructed from a durable and non-corrosive material, such as, for example, stainless steel. The distal coupling end 304 of connector 300 can be constructed to make a sealing engagement with a corresponding Luer-type connector of an arterial or venous catheter, for example. The inner annular surface 312 of the cap 310—in part or in whole—can make contact with any liquid present within the lumen 314 of the connector. As shown in FIG. 5B, an O-ring 316 or a suitable sealant can be placed between the cap electrode 310 and the proximal end 302 of the connector to maintain a fluid-tight connection between the connector and any flexible tubing attached to the connector.


An elastomeric O-ring may be particularly useful in hemodialysis or other extracorporeal systems in which the blood-carrying components are subjected to disinfection or sterilization using heated liquids. The thermal coefficients of expansion of the plastic components of a connector may be sufficiently different from that of an incorporated metal electrode that a permanent seal may not be preserved after one or more sterilization or disinfection procedures. Adding an elastomeric component such as an O-ring at the junction between an electrode and the connector seat on which it is positioned may preserve the seal by accommodating the different rates of expansion and contraction between the electrode and the connector.


As shown in FIG. 6, in one embodiment, a conductive electrode 310 (constructed of, e.g., stainless steel) can be incorporated into a portion of a connector 300 (either at its proximal end 302, or alternatively at its distal connecting end 304), over which the end of a flexible tubing 318 can be placed. In this embodiment, the electrode 310 is generally cylindrical, and has a taper 320 on a proximal end to permit an easier slip-fit attachment of the end of a segment of flexible tubing 318 over the outside surface of the electrode 310. As shown in FIG. 6, the internal surface of the electrode 310 has an internal ledge 322 that allows the electrode cap 310 to slip over and abut a proximal end 302 of connector 300. Connector 300 can be constructed of any suitable hard material, including metal or more typically a plastic material. The ledge 322 helps to ensure that a smaller diameter inner surface 312 of electrode 310 is properly positioned to make contact with any liquid (e.g. blood) that passes through the lumen 314 of connector 300. The connections between connector 300 and electrode 310, and electrode 310 and the termination of an overlying flexible tubing 318 can be made air tight or permanent with any suitable adhesive compatible with the compositions of the components.


To ensure a more secure seal to prevent blood leakage between the connector and electrode, and to limit the area under the electrode where blood elements may migrate and become lodged, an O-ring 316 can be incorporated into the inner surface of electrode 310 near the electrode internal ledge 320. This is seen in enlarged detail in FIG. 6. In this example, the O-ring 316 seals between the stainless steel electrode 310 and the distal end 302 of connector 300. A barb element 324 on the proximal end 302 of connector 300 can be incorporated in the connector design in order to hold the stretched end of the flexible tubing 318 onto the proximal end 302 of connector 300. In an embodiment, the electrode 310 is held in place by the portion of the flexible tube that is stretched over both the electrode 310 and the barb 324 of connector 300.


A wire 326 can be soldered, welded or otherwise secured onto the outer surface of electrode 310, and can travel under the overlying stretched tubing 318 until exiting more distally along the connector 300. The wire can thus conduct electrical signals to and from the electrode 310 as the internal surface 312 makes contact with the intraluminal fluid (e.g. blood). In the example shown, wire 326 is soldered to a distal portion of electrode 310 and travels under tubing 318, to emerge at the abutment of tubing 318 with a corresponding stop 326 of connector 300.


In another embodiment as shown in FIGS. 7A-7C, a connector 400 as described in U.S. Patent Application Publication No. 2010/0056975 (the contents of which are hereby incorporated by reference) has been modified so that a mid-portion 406 of the connector 400 can incorporate an electrode. Placement of the electrode along the mid-portion 406 of the connector 400 avoids having to alter the distal coupling end 404 of the connector, and avoids any alteration of the interaction between the termination of the flexible tubing and the proximal end 402 of the connector. In this example, the blood line connector 400 is constructed to make two different types of sealing connections on its distal coupling end 404, including an internal screw-type connection 405 for a Luer-type connector of a patient access line, and an external press-in type connection 407 with a dialysis machine port for recirculation of priming and disinfecting fluid through the blood carrying components of a dialysis system. The press-in feature 407 is formed having a frustoconical shape on the outside surface of the distal end 404 of the connector 400, while the Luer-compatible screw-type feature 405 is formed on the corresponding internal surface of the distal end 404 of the connector 400. The outside surface of the frustoconical member is constructed to make sealing engagement with the seat of a mating connector of a dialysis machine 200 or other device. A pair of locking arms 408 extending proximally from the distal coupling end 404 of the connector 400 can each have a barbed portion 409 to engage a corresponding locking feature on a mating connector on the dialysis machine, and a finger depression portion 410 to aid in disengaging the barbed portions 409 from the dialysis machine. The barbed portion 409 helps to lock the frustoconical member in sealing engagement with its mating connector on the dialysis machine when making a press-in type of connection. The distal ends of the locking arms can be constructed to attach to the connector via a flange 411 located proximal to the frustoconical portion 407 of the connector 400. The connector 400 has a proximal tubing attachment end 402 to sealingly engage a flexible tube. The tubing attachment end 402 may have one or more barb features 412 to help prevent disengagement of the end of a flexible tube from the connector 400.



FIG. 7B shows a side view of connector 400, bringing into view an access feature or port 420 that can permit placement of an electrode in direct communication with the lumen of connector 400. In other embodiments, the access feature may house an elastomeric stopper—with or without a septum—to permit sampling of fluid from within the lumen 414 of connector 400 using a syringe with a sharp or blunt needle. Alternatively, the feature may serve as a port to allow connection of another fluid line to the lumen 414 of connector 400.


In yet another embodiment, the mid-portion 406 of connector 400 may have two access ports, as shown in the cross-sectional view of FIG. 7C. A fluid access port 420a can serve as a sampling port, and an electrode port 420b can serve as an electrode cradle. An elastomeric stopper 422 within sampling port 420a can be shaped to extend to the lumen 414 of connector 400, simultaneously permitting sampling of fluid in the lumen 414 with a needle, while maintaining an air-tight seal. Alternatively, a Luer-type connector having a septated cap or seal can be incorporated into the port, which is capable of connecting with a syringe or catheter having a mating Luer-type connector. An electrode port 420b can serve as a seat or cradle for an electrode 424. In can be press-fit or cemented into position, and sealed with an adhesive, or with an O-ring 416 as shown. A wire 426 can be soldered, welded or otherwise secured onto the outer surface of electrode 424, and can travel proximally toward dialysis machine 200 with the arterial tubing 108 or venous tubing 126 to which connector 400 is attached.


In any of the above electrode embodiments, the electrodes may be replaced by a suitably sized thermistor, or combination of a thermistor and electrical conductor, for the additional purpose of monitoring the temperature of the fluid passing through connector 300, 400 or variants thereof.


Wire Assembly


In one embodiment, the wires carrying electrical signals to or from a pair of electrodes on connectors 106, 128 (one on the arterial side and one on the venous side of the blood flow circuit) can travel separate and apart from the blood tubing 108, 126 back toward dialysis machine 200, where they ultimately terminate and connect to, a conductivity detecting circuit, such as the conductivity circuit shown in FIG. 1. The conductivity circuit, in turn, provides an appropriately configured signal to a processor on the dialysis machine to determine whether a change in fluid conductivity consistent with an access disconnection has occurred. If so, the processor can trigger an alarm condition, or can initiate a shut-down of blood pump 114, and trigger a mechanical occlusion of blood tubing 108 and/or 126, for example.


Wires that extend together or separately between the dialysis machine and the patient are at risk of getting tangled, broken or becoming disconnected. Therefore, preferably, each wire 326 or 426 can be attached, fused, or otherwise incorporated into its associated tubing 108, 128. Incorporating a wire into its associated tubing provides a convenient way of protecting the wires and connections, and simplifying the interface between the patient and the dialysis apparatus. Exemplary methods of achieving this are shown in FIGS. 8A-8D. In a preferred embodiment, the tubing is comprised of a flexible material (e.g., silicone) that can be formed in an extrusion process. As shown in FIG. 8A, a loose wire mesh may be embedded in the flexible silicone tubing as it is formed and extruded, similar to fiber reinforcement of flexible tubing. As shown in FIG. 5A, a wire mesh 500 can be embedded within the wall of the flexible tubing 502 during extrusion, in a manner similar to the construction of a fiber-reinforced tube. As shown in FIG. 8B, an insulated wire 504 can be joined to the external surface of its adjacent tubing 506, either during a secondary extrusion process, or a process in which the two structures are joined by an adhesive, for example. As shown in FIG. 8C, a second extrusion producing a secondary concentric layer of tubing material 508 can be made to capture a wire running along the external surface of the tubing after the primary extrusion. As shown in FIG. 8D, the tubing 510 during formation can also be co-extruded with a wire 512 embedded in the wall of the tubing.


In some of the above methods, the resulting tube-wire combination may have a tendency to curl because of the difference in thermal coefficients of expansion between the wire and the silicone material of the tubing. As the material cools after extrusion, the silicone may capture the embedded wire tightly, causing the cooled tube-wire bundle to curl. In a preferred embodiment, the wire lumen of the extrusion die is constructed to be large enough to accommodate a cross-sectional area significantly larger than the cross-sectional area of the wire to be embedded. Then as the silicone cools, the passageway surrounding the wire does not shrink to the point of tightly encasing the wire. A co-extrusion process incorporating an insulated wire can generate a tube-wire bundle as shown in FIG. 9. In this example, flexible tubing 514 is a co-extrusion of a fluid-carrying lumen 516 and a wire-carrying lumen 518. Preferably, the wire 520 is multi-stranded for flexibility and durability, and is coated or sheathed in a durable, flexible synthetic insulating material 522, such as, for example, PTFE. A PTFE-based sheath 522 of the stranded wire 520 can sustain the high temperatures associated with the silicone tubing extrusion process, so that its integrity is maintained along the section 524 of the wire that ultimately exits the tubing for connection either to the dialysis machine 200 or the patient line connectors 106, 128. A coating or sheathing may also help prevent the wire from adhering to the side walls of the wire-carrying lumen after extrusion and during cooling.



FIG. 10 shows a cross-sectional view of an exemplary connector-wire-tubing assembly. The proximal tubing connection end of a connector 400 is shown with the end of a double-lumen tubing 514 attached. The fluid-carrying lumen 516 is press-fit and/or cemented to the proximal end of connector 400, allowing for fluid flow through the central lumen 414 of connector 400. Stranded wire 520 is soldered or otherwise attached to electrode 424, which is in conductive contact with any fluid present within the lumen 414 of connector 400. The non-connecting portion of the wire 520 that travels outside tubing 514 is preferably sheathed in an insulating synthetic coating, such as, for example, PTFE. Optionally, this portion of both the exposed and sheathed wire may also be sealed with a sealant, such as RTV. The sheathed wire 522 enters the wire-carrying lumen 518 of tubing 514 near its termination onto connector 400. The wire/tubing bundle then makes its way toward the dialysis machine 200, where the wire emerges from the tubing to make a connection to a conductivity circuit such as the one shown in FIG. 1.



FIG. 11 shows an exemplary extracorporeal circuit 210 that may be used as a removable, replaceable unit in a hemodialysis apparatus 220 as shown in FIG. 12. In this embodiment, the extracorporeal circuit comprises a blood pump cassette 114, dialyzer 118, venous return air trap 122, arterial blood tubing 108, venous blood tubing 126, arterial catheter connector 106, and venous catheter connector 128. The arterial 106 and venous 128 connectors may be of a type similar to the connector 300 shown in FIGS. 5A and 5B, or similar to the connector 400 shown in FIGS. 7A-7C, or variants thereof. The arterial 108 and venous 126 blood tubes may be of a type shown in FIGS. 8A-8D, or FIG. 9. Wires forming terminal connections to electrodes on connectors 106 and 128 may exit arterial 106 and venous 126 tubes as segments 524A and 524B to make a connection with a connector that ultimately passes the connection through on the dialysis apparatus to terminals associated with a conductivity circuit such as that shown in FIG. 11n the embodiment shown, the connector 526 is mounted to a support structure 212 for the blood pump 114 and air trap 122.



FIG. 12 shows an exemplary hemodialysis apparatus 220 that is configured to receive the extracorporeal circuit 210 shown in FIG. 11. In this illustration, the dialyzer 118 is already mounted onto the apparatus 220. A base unit 220 receives the control ports of a mating blood pump cassette 114. Sets of raceways or tracks 222 help to organize the pair of arterial 106 and venous 126 blood tubes when not extended out and connected with a patient. A connector 224 receives and passes through the connections made between wire segments 524A and 524B and connector 526 to the terminal connections of a conductivity circuit such as that shown in FIG. 1. A tubing occluder 226 is positioned to receive venous blood tube 126 after it exits air trap 122, and arterial blood tube 108 before it reaches blood pump cassette 114. The occluder 226 may be actuated pneumatically or electromechanically, for example, whenever an alarm condition occurs that requires cessation of extracorporeal blood flow. A set of arms of occluder 226 can be configured to rotate against the walls of the flexible tubes, constricting or stopping fluid flow within them. Thus, a controller installed within apparatus 220 can receive a signal from a conductivity circuit similar to FIG. 1, the signal representing the electrical resistance of the column of fluid or blood between the electrodes mounted on connectors 106 and 128. Because the connectors are positioned much closer fluidically to the patient's blood vessel or fistula 134 than to the blood pump 114, dialyzer 118 and air trap 122, the signal associated with the fluid path through the blood vessel or fistula 134 can discriminate between an intact and an interrupted column of blood or fluid between the connectors 106/128 and the patient's blood vessel or fistula 134. The controller can be programmed to respond to an electrical resistance detected by the conductivity circuit found to exceed a pre-determined value. Depending on the circumstances, the controller may then trigger an alarm to alert the patient to a possible disconnection of blood flow, and may also optionally command the occluder 226 to cease extracorporeal flow to and from the patient.


Operation of the Disconnect Detection Circuit



FIG. 13 shows test results utilizing the disconnect detection circuit described above and shown in FIG. 1. In this case, a hemodialysis blood circuit and apparatus was employed that is similar to that disclosed in U.S. Patent Application Publication Nos. 2009/0114582 and 2010/0056975, (the contents of which are hereby incorporated by reference). The extracorporeal circuit 210 shown in FIG. 11, comprises a blood pump 114, dialyzer 118, air trap 122, venous blood circuit tubing 126, and arterial blood circuit tubing 108. Extracorporeal circuit 210 mates to a hemodialysis apparatus 220 similar to the one shown in FIG. 12. The blood flow circuit tested included a pair of membrane-based blood pumps arranged on a blood pump cassette 114 shown in FIG. 11, a dialyzer 118, a venous return air trap 122, an arterial blood tubing set 108, a venous blood tubing set 126, arterial and venous connectors 106 and 128, and catheter tubing sets 104, 130 connected to vascular access needles 102, 132 as shown in FIG. 4. The needles 102, 132 were placed in a container holding anticoagulated bovine blood. The blood tubing set 108 and 126 was approximately six feet long, and the catheter tubing sets 104 and 130 were approximately two feet long or less. The needles were alternately manually placed in or withdrawn from the container during blood flow to simulate disconnection of a needle from a fistula or blood vessel. Periods A, C and F in FIG. 13 represent the times during which the needles were submerged in the blood in the container. The electrical resistance measured by the disconnect detection circuit shown in FIG. 1 during these periods averaged between 120,000 and 130,000 ohms. Periods B and E in FIG. 13 represent the times during which the venous return needle 132 (under positive pressure from the blood pumps) was withdrawn several centimeters above the surface of the blood within the container, forming a stream of blood mixed with air as the blood exited the venous return needle and entered the container of blood below. The electrical resistance measured during these periods averaged between 140,000 and 150,000 ohms. Period D represents the time during which one of the needles was completely removed from the container, creating a fully open electrical circuit. The electrical resistance measured during this period averaged between about 160,000 and 180,000 ohms. Thus a controller can be readily programmed to distinguish the difference in the monitored resistance of the electrical circuit between an uninterrupted and an interrupted flow of blood. These results showed that an interruption of the continuity of the blood between the arterial 102 and venous 132 needles can reliably produce a detectable change in the measured electrical resistance between two electrodes when placed relatively closer to the arterial and venous access sites than to the blood processing components 114, 118 and 122 of the extracorporeal blood circuit. Furthermore, even a partial interruption of the continuity of blood flow (as in the streaming of blood through air) can be reliably detected, albeit with a smaller change in the measured electrical resistance.

Claims
  • 1. A system for detecting the disconnection of a vascular access device from a blood vessel or vascular graft, comprising: a fluid delivery device for pumping fluid through a first tube connected to a first catheter in a first site of the blood vessel or graft, and for receiving fluid through a second tube connected to a second catheter in a second site of the blood vessel or graft;a first connector configured to connect the first tube to the first catheter, and a second connector configured to connect the second tube to the second catheter, the first connector having a first electrode in fluid communication with a lumen of said first connector, and the second connector having a second electrode in fluid communication with a lumen of said second connector;each said first and second electrodes electrically connected to respective first and second terminals of an electronic circuit;the electronic circuit configured to deliver electrical signals to the first and second terminals in order to measure an electrical resistance of a fluid in a fluid path extending from the lumen of the first connector, through the blood vessel or vascular graft, to the lumen of the second connector;the electronic circuit comprising:a switching network coupled by a capacitor to each of the first and second terminals and configured to provide the electrical signals to the first and second terminals in alternating first and second switch configurations;a known reference resistance interposed between the capacitor for the first terminal and the switching network; anda voltage measuring circuit configured to measure a sense voltage between the capacitor of the first terminal and the known reference resistance;wherein the electronic circuit is configured to determine the electrical resistance of the fluid based on a value of the reference resistance, a measured sense voltage for the first switch configuration and a measured sense voltage for the second switch configuration.
  • 2. The system of claim 1, wherein each said first and second electrode is electrically connected to a corresponding one of the first and second terminals of the electronic circuit through a wire located in a second lumen of a double lumen tube, a first lumen of said double lumen tube configured to carry blood between the fluid delivery device and the first or second catheter.
  • 3. The system of claim 1, wherein the first and second tubes are longer than the first and second catheters.
  • 4. The system of claim 1, wherein the electrical signal corresponding to the first switch configuration is a first reference voltage and the electrical signal corresponding to the second switch configuration is a second reference voltage lower than the first reference voltage.
  • 5. The system of claim 4, further comprising a voltage divider that creates the first and second reference voltages.
  • 6. The system of claim 5, wherein the voltage divider is provided with a main reference voltage Vref from which the voltage divider creates the first and second reference voltages.
  • 7. The system of claim 6, wherein the first reference voltage is close to the main reference voltage Vref and the second reference voltage is close to a ground reference voltage.
  • 8. The system of claim 1, wherein the voltage measuring circuit is arranged to measure the sense voltage before and after each time the switching network changes between the first and second switch configurations, and to determine a change in sense voltage as a difference between the sense voltage measured before and after each time the switching network changes between the first and second switch configurations.
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. application Ser. No. 12/916,021, filed Oct. 29, 2010, and entitled “Apparatus and Method for Detecting Disconnection of an Intravascular Access Device,” which claims priority from U.S. Provisional Patent Application Ser. No. 61/256,735, filed Oct. 30, 2009 and entitled “Device and Method for Detecting Disconnection of an Intravascular Access Device,” which are incorporated herein by reference in their entirety.

US Referenced Citations (578)
Number Name Date Kind
1693526 Owens Nov 1928 A
2529028 Landon Nov 1950 A
2741099 Beane Apr 1956 A
2816514 Freese Dec 1957 A
3016563 De Jong Jan 1962 A
3200648 Waggaman Aug 1965 A
3508656 Serfass et al. Apr 1970 A
3539081 Norton et al. Nov 1970 A
3656873 Schiff Apr 1972 A
3759483 Baxter Sep 1973 A
RE27849 Wortman Dec 1973 E
3827561 Serfass et al. Aug 1974 A
3847809 Kopf Nov 1974 A
3882861 Kettering et al. May 1975 A
3908441 Virloget Sep 1975 A
3936729 Winslow Feb 1976 A
4085047 Thompson Apr 1978 A
4096211 Rameau Jun 1978 A
4096859 Agarwal et al. Jun 1978 A
4133312 Burd Jan 1979 A
4155852 Fischel et al. May 1979 A
4161264 Malmgren et al. Jul 1979 A
4181610 Shintani et al. Jan 1980 A
4227814 Soodak et al. Oct 1980 A
4266814 Gallagher May 1981 A
4267040 Schal et al. May 1981 A
4282099 Jones Aug 1981 A
4299784 Hense Nov 1981 A
4309592 Le Boeuf Jan 1982 A
4322054 Campbell Mar 1982 A
4362156 Feller et al. Dec 1982 A
4369781 Gilson et al. Jan 1983 A
4398908 Siposs Aug 1983 A
4411783 Dickens et al. Oct 1983 A
4439188 Dennehy et al. Mar 1984 A
4441357 Kahn et al. Apr 1984 A
4479760 Bilstad et al. Oct 1984 A
4479761 Bilstad et al. Oct 1984 A
4479762 Bilstad et al. Oct 1984 A
4490254 Gordon et al. Dec 1984 A
4492258 Lichtenstein et al. Jan 1985 A
4501405 Usry Feb 1985 A
4574876 Aid Mar 1986 A
4585442 Marines Apr 1986 A
4623334 Riddell Nov 1986 A
4623450 Vantard et al. Nov 1986 A
4656427 Dauphinee et al. Apr 1987 A
4664891 Cosentino et al. May 1987 A
4680445 Ogawa Jul 1987 A
4695385 Boag Sep 1987 A
4718022 Cochran Jan 1988 A
4731072 Aid Mar 1988 A
4745279 Karkar et al. May 1988 A
4767526 Vantard Aug 1988 A
4770769 Schael et al. Sep 1988 A
4778451 Kamen Oct 1988 A
4784495 Jonsson et al. Nov 1988 A
4808161 Kamen Feb 1989 A
4822343 Beiser Apr 1989 A
4826482 Kamen May 1989 A
4828543 Weiss et al. May 1989 A
4829448 Balding et al. May 1989 A
4833329 Quint et al. May 1989 A
4863461 Jarvik Sep 1989 A
4884065 Crouse et al. Nov 1989 A
4906816 van Leerdam Mar 1990 A
4927411 Pastrone et al. May 1990 A
4950235 Slate et al. Aug 1990 A
4971700 Tsuji et al. Nov 1990 A
4976162 Kamen Dec 1990 A
4976729 Holfert et al. Dec 1990 A
4997570 Polaschegg Mar 1991 A
5024756 Sternby Jun 1991 A
5033513 Bartholomew Jul 1991 A
5061241 Stephens, Jr. et al. Oct 1991 A
5062774 Kramer et al. Nov 1991 A
5074838 Kroyer Dec 1991 A
5088515 Kamen Feb 1992 A
5088901 Brauer Feb 1992 A
5100554 Polaschegg Mar 1992 A
5105981 Gehman Apr 1992 A
5110447 MacWilliams et al. May 1992 A
5110477 Howard et al. May 1992 A
5116316 Sertic et al. May 1992 A
5125069 O'Boyle Jun 1992 A
5160325 Nichols et al. Nov 1992 A
5178182 Kamen Jan 1993 A
5245693 Ford et al. Sep 1993 A
5247434 Peterson et al. Sep 1993 A
5267956 Beauchat Dec 1993 A
5278072 Wall et al. Jan 1994 A
5300044 Classey et al. Apr 1994 A
5306242 Joyce et al. Apr 1994 A
5324422 Colleran et al. Jun 1994 A
5326476 Grogan et al. Jul 1994 A
D350823 Lanigan Sep 1994 S
D350850 Angelini Sep 1994 S
5349896 Delaney, III et al. Sep 1994 A
5350357 Kamen et al. Sep 1994 A
5351686 Steuer et al. Oct 1994 A
5378126 Abrahamson et al. Jan 1995 A
5381510 Ford et al. Jan 1995 A
5385540 Abbott et al. Jan 1995 A
5395316 Martin Mar 1995 A
5410255 Bailey Apr 1995 A
5411472 Steg, Jr. et al. May 1995 A
5413566 Sevrain et al. May 1995 A
5420962 Bakke May 1995 A
5421823 Kamen et al. Jun 1995 A
5423738 Robinson et al. Jun 1995 A
5429485 Dodge Jul 1995 A
5431626 Bryant et al. Jul 1995 A
5438510 Bryant et al. Aug 1995 A
5441231 Payne et al. Aug 1995 A
5441343 Pylkki et al. Aug 1995 A
5441636 Chevallet et al. Aug 1995 A
5469070 Koluvek Nov 1995 A
5472614 Rossi Dec 1995 A
5474683 Bryant et al. Dec 1995 A
5476368 Rabenau et al. Dec 1995 A
5476444 Keeling et al. Dec 1995 A
5482440 Dennehey et al. Jan 1996 A
5486286 Peterson et al. Jan 1996 A
5487827 Peterson et al. Jan 1996 A
5496273 Pastrone et al. Mar 1996 A
5527507 Childers et al. Jun 1996 A
5541344 Becker et al. Jul 1996 A
5542919 Simon et al. Aug 1996 A
5558255 Sancoff et al. Sep 1996 A
5568362 Hansson Oct 1996 A
5575310 Kamen et al. Nov 1996 A
5578012 Kamen et al. Nov 1996 A
5580460 Polaschegg et al. Dec 1996 A
5586438 Fahy et al. Dec 1996 A
5591344 Kenley et al. Jan 1997 A
5591389 Esrock Jan 1997 A
5593290 Greisch et al. Jan 1997 A
5601080 Oppenheimer Feb 1997 A
5609572 Lang Mar 1997 A
5628908 Kamen et al. May 1997 A
5632894 White et al. May 1997 A
5634896 Bryant et al. Jun 1997 A
5645531 Thompson et al. Jul 1997 A
5651765 Haworth et al. Jul 1997 A
5651893 Kenley et al. Jul 1997 A
5651898 Imura Jul 1997 A
5680111 Danby et al. Oct 1997 A
5690831 Kenley et al. Nov 1997 A
5692729 Harhen Dec 1997 A
5702597 Chevallet et al. Dec 1997 A
5729653 Magliochetti et al. Mar 1998 A
5730720 Sites et al. Mar 1998 A
5734464 Gibbs Mar 1998 A
5744027 Connell et al. Apr 1998 A
5755275 Rose et al. May 1998 A
5755683 Houle et al. May 1998 A
5776091 Brugger et al. Jul 1998 A
5782508 Bartholomew Jul 1998 A
5797897 Jepson et al. Aug 1998 A
5804979 Lund et al. Sep 1998 A
5857379 Lulofs et al. Jan 1999 A
5875282 Jordan et al. Feb 1999 A
5879316 Safar et al. Mar 1999 A
5882047 Ostrander et al. Mar 1999 A
5899873 Jones et al. May 1999 A
5902476 Twardowski et al. May 1999 A
5931648 Del Canizo Aug 1999 A
5932103 Kenley et al. Aug 1999 A
5932110 Shah et al. Aug 1999 A
5938634 Packard Aug 1999 A
5947931 Bierman et al. Sep 1999 A
5989423 Kamen et al. Nov 1999 A
6039877 Chevallet et al. Mar 2000 A
6041801 Gray et al. Mar 2000 A
6042784 Wamsiedler et al. Mar 2000 A
6044868 Gretz et al. Apr 2000 A
6047108 Sword et al. Apr 2000 A
6062068 Bowling et al. May 2000 A
6070761 Bloom et al. Jun 2000 A
6089105 Ricciardelli Jul 2000 A
6101406 Hacker et al. Aug 2000 A
6109881 Snodgrass et al. Aug 2000 A
6136201 Shah et al. Oct 2000 A
6139534 Niedospial, Jr. et al. Oct 2000 A
6139819 Unger et al. Oct 2000 A
6142164 Wier et al. Nov 2000 A
6142446 Leinsing Nov 2000 A
6146354 Beil Nov 2000 A
6146523 Kenley et al. Nov 2000 A
6146536 Twardowski Nov 2000 A
6153102 Kenley et al. Nov 2000 A
6159192 Fowles et al. Dec 2000 A
6171261 Niermann et al. Jan 2001 B1
6176904 Gupta Jan 2001 B1
6195887 Danby et al. Mar 2001 B1
6210361 Kamen et al. Apr 2001 B1
6213996 Jepson et al. Apr 2001 B1
6223130 Gray et al. Apr 2001 B1
6234997 Kamen et al. May 2001 B1
6264680 Ash Jul 2001 B1
RE37324 Esrock Aug 2001 E
6274303 Wowk et al. Aug 2001 B1
6277277 Jacobi et al. Aug 2001 B1
6284131 Hogard et al. Sep 2001 B1
6302653 Bryant et al. Oct 2001 B1
6321597 Demers et al. Nov 2001 B1
6331778 Dailey et al. Dec 2001 B1
6336003 Mitsunaga et al. Jan 2002 B1
6336911 Westerbeck Jan 2002 B1
6347633 Groth et al. Feb 2002 B1
6382923 Gray May 2002 B1
6406426 Reuss et al. Jun 2002 B1
6406452 Westerbeck Jun 2002 B1
6413233 Sites et al. Jul 2002 B1
6415797 Groth et al. Jul 2002 B1
6416293 Bouchard et al. Jul 2002 B1
6423053 Lee Jul 2002 B1
6464666 Augustine et al. Oct 2002 B1
6480257 Cassidy et al. Nov 2002 B2
6485263 Bryant et al. Nov 2002 B1
6491656 Morris Dec 2002 B1
6497676 Childers et al. Dec 2002 B1
6510330 Enejder Jan 2003 B1
6517510 Stewart et al. Feb 2003 B1
6520747 Gray et al. Feb 2003 B2
6527758 Ko Mar 2003 B2
6529775 Whitebook et al. Mar 2003 B2
6535689 Augustine et al. Mar 2003 B2
6537445 Muller Mar 2003 B2
6539172 Akahane Mar 2003 B2
6543814 Bartholomew Apr 2003 B2
6579253 Burbank et al. Jun 2003 B1
6579496 Fausset et al. Jun 2003 B1
RE38203 Kelly Jul 2003 E
6595944 Balschat et al. Jul 2003 B2
6595948 Suzuki et al. Jul 2003 B2
6604908 Bryant et al. Aug 2003 B1
6608968 Bakke Aug 2003 B2
6620119 Utterberg et al. Sep 2003 B1
6635491 Khalil et al. Oct 2003 B1
6638478 Treu et al. Oct 2003 B1
6649063 Brugger et al. Nov 2003 B2
6660974 Faries, Jr. et al. Dec 2003 B2
6663353 Lipscomb et al. Dec 2003 B2
6663359 Gray Dec 2003 B2
6663585 Ender Dec 2003 B1
6673314 Burbank et al. Jan 2004 B1
6687004 Shana et al. Feb 2004 B1
6709417 Houle et al. Mar 2004 B1
6722865 Domroese Apr 2004 B2
6723062 Westberg et al. Apr 2004 B1
6726656 Kamen et al. Apr 2004 B2
6743201 Doing et al. Jun 2004 B1
6749403 Bryant et al. Jun 2004 B2
6752172 Lauer Jun 2004 B2
6758975 Peabody et al. Jul 2004 B2
6768085 Faries et al. Jul 2004 B2
6775473 Augustine et al. Aug 2004 B2
6788885 Mitsunaga et al. Sep 2004 B2
6808369 Gray et al. Oct 2004 B2
6814547 Childers et al. Nov 2004 B2
6814718 McGuckin, Jr. et al. Nov 2004 B2
6826948 Bhatti et al. Dec 2004 B1
6852090 Burbank et al. Feb 2005 B2
6858019 McGuckin, Jr. et al. Feb 2005 B2
6860866 Graf et al. Mar 2005 B1
6868309 Begelman Mar 2005 B1
6877713 Gray et al. Apr 2005 B1
6905314 Danby Jun 2005 B2
6905479 Bouchard et al. Jun 2005 B1
6929751 Bowman et al. Aug 2005 B2
6939471 Gross et al. Sep 2005 B2
6946299 Neel et al. Sep 2005 B2
6949079 Westberg et al. Sep 2005 B1
6953323 Childers et al. Oct 2005 B2
7029245 Maianti et al. Apr 2006 B2
7041076 Westberg et al. May 2006 B1
7060047 Lodi et al. Jun 2006 B2
7083719 Bowman et al. Aug 2006 B2
7122210 Elisabettini et al. Oct 2006 B2
7124996 Clarke et al. Oct 2006 B2
7138088 Wariar et al. Nov 2006 B2
7147613 Burbank et al. Dec 2006 B2
7153286 Busby et al. Dec 2006 B2
7168334 Drott Jan 2007 B1
7169303 Sullivan et al. Jan 2007 B2
7175397 Claude et al. Feb 2007 B2
7175606 Bowman et al. Feb 2007 B2
7214210 Kamen et al. May 2007 B2
7230687 O'Mahony et al. Jun 2007 B2
7238164 Childers et al. Jul 2007 B2
7273465 Ash Sep 2007 B2
7300413 Burbank et al. Nov 2007 B2
7303540 O'Mahony et al. Dec 2007 B2
7318292 Helbling et al. Jan 2008 B2
7318892 Connell et al. Jan 2008 B2
7410294 Shiraki et al. Aug 2008 B2
7461968 Demers et al. Dec 2008 B2
7465285 Hutchinson et al. Dec 2008 B2
7476209 Gara et al. Jan 2009 B2
7488448 Wieting et al. Feb 2009 B2
7500962 Childers et al. Mar 2009 B2
7530962 Ross et al. May 2009 B2
7544179 Distler et al. Jun 2009 B2
7559524 Gray et al. Jul 2009 B2
7601636 Dumas et al. Oct 2009 B2
7632078 Demers et al. Dec 2009 B2
7632080 Tracey et al. Dec 2009 B2
7644889 Johnson Jan 2010 B2
7662286 Childers et al. Feb 2010 B2
7699806 Ware et al. Apr 2010 B2
7717682 Orr May 2010 B2
7727176 Tonelli et al. Jun 2010 B2
7741756 Sudol Jun 2010 B2
7744553 Kelly et al. Jun 2010 B2
7776301 Comrie et al. Aug 2010 B2
7789849 Busby et al. Sep 2010 B2
7794141 Perry et al. Sep 2010 B2
7815595 Busby et al. Oct 2010 B2
7867214 Childers et al. Jan 2011 B2
7892197 Folden et al. Feb 2011 B2
7896830 Gura et al. Mar 2011 B2
7899508 DeArmond Mar 2011 B2
7935074 Plahey et al. May 2011 B2
7935250 Castellano et al. May 2011 B2
7938792 Roger et al. May 2011 B2
7967022 Grant et al. Jun 2011 B2
8002726 Karoor et al. Aug 2011 B2
8042563 Grant et al. Oct 2011 B2
8066671 Busby et al. Nov 2011 B2
8075526 Busby et al. Dec 2011 B2
8137553 Fulkerson et al. Mar 2012 B2
8180443 Kleinekofort et al. May 2012 B1
8246826 Wilt et al. Aug 2012 B2
8248087 Ishino et al. Aug 2012 B2
8273049 Demers et al. Sep 2012 B2
8292594 Tracey et al. Oct 2012 B2
8298152 Konig et al. Oct 2012 B2
8317492 Demers et al. Nov 2012 B2
8357298 Demers et al. Jan 2013 B2
8393690 Grant et al. Mar 2013 B2
8409441 Wilt Apr 2013 B2
8425471 Grant et al. Apr 2013 B2
8459292 Wilt et al. Jun 2013 B2
8491184 Kamen et al. Jul 2013 B2
8499780 Wilt et al. Aug 2013 B2
8545698 Wilt et al. Oct 2013 B2
8562834 Kamen et al. Oct 2013 B2
8708950 Scarpaci et al. Apr 2014 B2
8721879 van der Merwe et al. May 2014 B2
8721884 Wilt et al. May 2014 B2
8771508 Grant et al. Jul 2014 B2
8858787 Muller et al. Oct 2014 B2
8863772 Dale et al. Oct 2014 B2
8870549 Tracey et al. Oct 2014 B2
8888470 Demers et al. Nov 2014 B2
8926294 Demers et al. Jan 2015 B2
8968232 Kamen et al. Mar 2015 B2
8985133 Grant et al. Mar 2015 B2
8992075 Kamen et al. Mar 2015 B2
8992189 Wilt et al. Mar 2015 B2
9028691 Grant et al. May 2015 B2
9115708 van der Merwe et al. Aug 2015 B2
9272082 Demers et al. Mar 2016 B2
9302037 Wilt et al. Apr 2016 B2
9364655 Grant et al. Jun 2016 B2
9366781 Scarpaci et al. Jun 2016 B2
9517295 Wilt et al. Dec 2016 B2
9535021 Kamen et al. Jan 2017 B2
9539379 Grant et al. Jan 2017 B2
9550018 Demers et al. Jan 2017 B2
9555179 Wilt et al. Jan 2017 B2
9597442 Wilt Mar 2017 B2
9603985 Wilt et al. Mar 2017 B2
9649418 Demers et al. May 2017 B2
9677554 Wilt et al. Jun 2017 B2
9700660 Demers et al. Jul 2017 B2
9700711 Grant et al. Jul 2017 B2
9717834 Wilt et al. Aug 2017 B2
9724458 Grant et al. Aug 2017 B2
9795728 Grant et al. Oct 2017 B2
9951768 Grant et al. Apr 2018 B2
9987407 Grant et al. Jun 2018 B2
9999717 van der Merwe et al. Jun 2018 B2
20020000871 Davies Jan 2002 A1
20020056672 Guy et al. May 2002 A1
20020092103 Bruno et al. Jul 2002 A1
20020103453 Burbank et al. Aug 2002 A1
20020150476 Lucke et al. Oct 2002 A1
20020179505 Rovatti et al. Dec 2002 A1
20020179595 Nagele Dec 2002 A1
20020182090 Gray Dec 2002 A1
20030036719 Giacomelli Feb 2003 A1
20030100858 Utterberg et al. May 2003 A1
20030114795 Faries et al. Jun 2003 A1
20030194328 Bryant et al. Oct 2003 A1
20030194332 Jahn et al. Oct 2003 A1
20030195453 Han et al. Oct 2003 A1
20030195454 Wariar et al. Oct 2003 A1
20030220599 Lundtveit et al. Nov 2003 A1
20030220607 Busby et al. Nov 2003 A1
20030229302 Robinson et al. Dec 2003 A1
20030230191 Ohrle et al. Dec 2003 A1
20040001766 Maianti et al. Jan 2004 A1
20040009096 Wellman Jan 2004 A1
20040019313 Childers et al. Jan 2004 A1
20040091374 Gray May 2004 A1
20040101026 Nitta et al. May 2004 A1
20040138607 Burbank et al. Jul 2004 A1
20040245161 Treu et al. Dec 2004 A1
20040262917 Sunohara et al. Dec 2004 A1
20050020958 Paolini et al. Jan 2005 A1
20050045540 Connell et al. Mar 2005 A1
20050069425 Gray et al. Mar 2005 A1
20050069427 Roemuss et al. Mar 2005 A1
20050095141 Lanigan et al. May 2005 A1
20050095154 Tracey et al. May 2005 A1
20050126998 Childers Jun 2005 A1
20050130332 Ishii et al. Jun 2005 A1
20050131332 Kelly et al. Jun 2005 A1
20050195087 Thompson et al. Sep 2005 A1
20050209563 Hopping et al. Sep 2005 A1
20050230292 Beden et al. Oct 2005 A1
20050234385 Vandlik Oct 2005 A1
20050242034 Connell et al. Nov 2005 A1
20050274658 Rosenbaum et al. Dec 2005 A1
20060002823 Feldstein Jan 2006 A1
20060093531 Tremoulet et al. May 2006 A1
20060184084 Ware et al. Aug 2006 A1
20060195064 Plahey et al. Aug 2006 A1
20060229586 Faries Oct 2006 A1
20060241550 Kamen et al. Oct 2006 A1
20070060786 Gura et al. Mar 2007 A1
20070060872 Hall et al. Mar 2007 A1
20070077156 Orr Apr 2007 A1
20070112297 Plahey et al. May 2007 A1
20070135758 Childers et al. Jun 2007 A1
20070166181 Nilson Jul 2007 A1
20070210047 Child Sep 2007 A1
20070253463 Perry et al. Nov 2007 A1
20070255527 Schick et al. Nov 2007 A1
20070278155 Lo et al. Dec 2007 A1
20080015493 Childers et al. Jan 2008 A1
20080033346 Childers et al. Feb 2008 A1
20080058697 Kamen et al. Mar 2008 A1
20080058712 Plahey Mar 2008 A1
20080065006 Roger et al. Mar 2008 A1
20080077068 Orr Mar 2008 A1
20080097283 Plahey Apr 2008 A1
20080105600 Connell et al. May 2008 A1
20080125693 Connell et al. May 2008 A1
20080132828 Howard Jun 2008 A1
20080161751 Plahey et al. Jul 2008 A1
20080175719 Tracey et al. Jul 2008 A1
20080202591 Grant et al. Aug 2008 A1
20080204086 Park et al. Aug 2008 A1
20080205481 Faries, Jr. et al. Aug 2008 A1
20080208103 Demers et al. Aug 2008 A1
20080208111 Kamen et al. Aug 2008 A1
20080215898 Lu et al. Sep 2008 A1
20080216898 Grant et al. Sep 2008 A1
20080240929 Kamen et al. Oct 2008 A1
20080253427 Kamen et al. Oct 2008 A1
20080253911 Demers et al. Oct 2008 A1
20080253912 Demers et al. Oct 2008 A1
20080287854 Sun Nov 2008 A1
20090004033 Demers et al. Jan 2009 A1
20090007642 Busby et al. Jan 2009 A1
20090008331 Wilt et al. Jan 2009 A1
20090009290 Knelp et al. Jan 2009 A1
20090012447 Huitt et al. Jan 2009 A1
20090012448 Childers et al. Jan 2009 A1
20090012449 Lee et al. Jan 2009 A1
20090012450 Childers et al. Jan 2009 A1
20090012452 Slepicka et al. Jan 2009 A1
20090012453 Childers et al. Jan 2009 A1
20090012454 Childers Jan 2009 A1
20090012455 Childers et al. Jan 2009 A1
20090012456 Childers et al. Jan 2009 A1
20090012457 Childers et al. Jan 2009 A1
20090012458 Childers et al. Jan 2009 A1
20090012460 Steck et al. Jan 2009 A1
20090012461 Childers et al. Jan 2009 A1
20090024070 Gelfand et al. Jan 2009 A1
20090043239 Gagel et al. Feb 2009 A1
20090076433 Folden et al. Mar 2009 A1
20090076434 Mischelevich et al. Mar 2009 A1
20090088675 Kelly et al. Apr 2009 A1
20090088683 Roger et al. Apr 2009 A1
20090095679 Demers et al. Apr 2009 A1
20090101549 Kamen et al. Apr 2009 A1
20090101550 Muller et al. Apr 2009 A1
20090101566 Crnkovich et al. Apr 2009 A1
20090105621 Boyd et al. Apr 2009 A1
20090105629 Grant et al. Apr 2009 A1
20090107335 Wilt et al. Apr 2009 A1
20090107902 Childers et al. Apr 2009 A1
20090112151 Chapman et al. Apr 2009 A1
20090113335 Sandoe et al. Apr 2009 A1
20090114582 Grant et al. May 2009 A1
20090154524 Girelli Jun 2009 A1
20090173682 Robinson et al. Jul 2009 A1
20090182263 Burbank et al. Jul 2009 A1
20090192367 Braig et al. Jul 2009 A1
20090202367 Gray et al. Aug 2009 A1
20100018317 Kitani et al. Jan 2010 A1
20100051529 Grant et al. Mar 2010 A1
20100051551 Grant et al. Mar 2010 A1
20100056975 Dale et al. Mar 2010 A1
20100057016 Dale et al. Mar 2010 A1
20100087777 Hopping et al. Apr 2010 A1
20100133153 Beden et al. Jun 2010 A1
20100137782 Jansson et al. Jun 2010 A1
20100185134 Houwen et al. Jul 2010 A1
20100187176 Lopez et al. Jul 2010 A1
20100190204 Gazenko Jul 2010 A1
20100192686 Kamen et al. Aug 2010 A1
20100204765 Hall et al. Aug 2010 A1
20100296953 Gray Nov 2010 A1
20100327849 Kamen et al. Dec 2010 A1
20110009797 Kelly et al. Jan 2011 A1
20110092875 Beck et al. Apr 2011 A1
20110105877 Wilt et al. May 2011 A1
20110144569 Britton et al. Jun 2011 A1
20110218600 Kamen et al. Sep 2011 A1
20110299358 Wilt et al. Dec 2011 A1
20110303588 Kelly et al. Dec 2011 A1
20110303598 Lo et al. Dec 2011 A1
20120035533 Britton et al. Feb 2012 A1
20120071816 Busby et al. Mar 2012 A1
20120106289 Wilt et al. May 2012 A1
20120123322 Scarpaci et al. May 2012 A1
20120207627 Demers et al. Aug 2012 A1
20130010825 Kamen et al. Jan 2013 A1
20130020237 Wilt et al. Jan 2013 A1
20130022483 Wilt et al. Jan 2013 A1
20130032536 Wilt et al. Feb 2013 A1
20130037480 Wilt et al. Feb 2013 A1
20130037485 Wilt et al. Feb 2013 A1
20130074959 Demers et al. Mar 2013 A1
20130115105 Tracey et al. May 2013 A1
20130126413 Van der Merwe et al. May 2013 A1
20130177457 Demers et al. Jul 2013 A1
20130284648 Grant et al. Oct 2013 A1
20130304020 Wilt et al. Nov 2013 A1
20130317454 Grant et al. Nov 2013 A1
20140102299 Wilt et al. Apr 2014 A1
20140102958 Kamen et al. Apr 2014 A1
20140102970 Wilt et al. Apr 2014 A1
20140112828 Grant et al. Apr 2014 A1
20140153356 Grant et al. Jun 2014 A1
20140199193 Wilt et al. Jul 2014 A1
20140299544 Wilt et al. Oct 2014 A1
20140309611 Wilt et al. Oct 2014 A1
20140319041 Wilt et al. Oct 2014 A1
20140322053 van der Merwe et al. Oct 2014 A1
20140323954 Scarpaci et al. Oct 2014 A1
20150042366 Wilt et al. Feb 2015 A1
20150050166 Tracey et al. Feb 2015 A1
20150196698 Grant et al. Jul 2015 A1
20150196699 Wilt et al. Jul 2015 A9
20150224242 Grant et al. Aug 2015 A1
20160030658 van der Merwe et al. Feb 2016 A1
20160058933 Ballantyne et al. Mar 2016 A1
20160175506 Wilt et al. Jun 2016 A1
20170000938 Wilt et al. Jan 2017 A1
20170100533 Wilt et al. Apr 2017 A1
20170130705 Demers et al. May 2017 A1
20170143886 Wilt et al. May 2017 A1
20170241926 Kamen et al. Aug 2017 A1
20170252503 Wilt Sep 2017 A1
20170296803 Grant et al. Oct 2017 A1
20170319765 Wilt et al. Nov 2017 A1
20170326282 Wilt et al. Nov 2017 A1
20170342972 Wilt et al. Nov 2017 A1
20170368252 Grant et al. Dec 2017 A1
20180038357 Demers et al. Feb 2018 A1
20180055984 Grant et al. Mar 2018 A1
Foreign Referenced Citations (58)
Number Date Country
1167430 Dec 1997 CN
2374187 Apr 2000 CN
1455262 Nov 2003 CN
1830494 Sep 2006 CN
101309710 Nov 2008 CN
101551354 Oct 2009 CN
3 328 744 Feb 1985 DE
10206666 Aug 2003 DE
0238809 Sep 1987 EP
0 687 474 Dec 1995 EP
0706044 Apr 1996 EP
0 815 882 Jan 1998 EP
0 992 255 Apr 2000 EP
2 319 551 May 2011 EP
2 423 241 Aug 2006 GB
S60-077782 May 1985 JP
H09-099060 Apr 1997 JP
H10-319052 Dec 1998 JP
H11-210633 Aug 1999 JP
2001-525229 Nov 2001 JP
2006-507024 Mar 2006 JP
2006-204343 Aug 2006 JP
2008-136673 Jun 2008 JP
WO 9420158 Sep 1994 WO
WO 9640320 Dec 1996 WO
WO 9709898 Mar 1997 WO
WO 9837801 Sep 1998 WO
WO 9839058 Sep 1998 WO
WO 9910028 Mar 1999 WO
WO 9929356 Jun 1999 WO
WO 0015278 Mar 2000 WO
WO 0137895 May 2001 WO
WO 0203879 Jan 2002 WO
WO 0230267 Apr 2002 WO
WO 03080268 Oct 2003 WO
WO 03086505 Oct 2003 WO
WO 2004041081 May 2004 WO
WO 2005044339 May 2005 WO
WO 2005044435 May 2005 WO
WO 2006013312 Feb 2006 WO
WO 2006088419 Aug 2006 WO
WO 2006120415 Nov 2006 WO
WO 2007058020 May 2007 WO
WO 2007120812 Oct 2007 WO
WO 2007126360 Nov 2007 WO
WO 2008028653 Mar 2008 WO
WO 2008106191 Sep 2008 WO
WO 2008106440 Sep 2008 WO
WO 2008106452 Sep 2008 WO
WO 2008106538 Sep 2008 WO
WO 2008118600 Oct 2008 WO
WO 2009051669 Apr 2009 WO
WO 2009094179 Jul 2009 WO
WO 2009094183 Jul 2009 WO
WO 2010027435 Mar 2010 WO
WO 2010027437 Mar 2010 WO
WO 2011053810 May 2011 WO
WO 2012006425 Jan 2012 WO
Non-Patent Literature Citations (60)
Entry
Office Action for MX Application No. MX/A/2015/001507 filed Jan. 30, 2015, which Office Action is dated Feb. 28, 2017, and claims as pending for MX Application No. MX/A/2015/001507 as of Feb. 28, 2017.
Office Action for JP Application No. 2016-198052 filed Oct. 6, 2016, which Office Action is dated Aug. 16, 2017, and claims as pending for JP Application No. 2016-198052.
Office Action for MX Application No. MX/A/2015/001507 filed Jan. 30, 2015, which Office Action is dated Jun. 4, 2015, and claims as pending for MX Application No. MX/A/2015/001507 as of Jun. 4, 2015.
Search Report and Written Opinion for SG Application No. 11201609765V filed May 27, 2015, which Report is dated Nov. 3, 2017, and claims as pending for SG Application No. 11201609765V as of Nov. 3, 2017.
International Search Report and Written Opinion for PCT/US2015/032702 dated Dec. 4, 2015.
International Preliminary Report on Patentability for PCT/US2015/032702 dated Dec. 8, 2016.
Office Action for MX Application No. MX/A/2015/001507 filed Jan. 30, 2015, which Office Action is dated Jun. 3, 2016, and claims as pending for MK Application No. MX/A/2015/001507 as of Jun. 3, 2016.
Office Action for JP Application No. 2009-551724 filed Feb. 27, 2008, which Office Action is dated Nov. 28, 2012, and claims as pending for JP Application No. 2009-551724 as of Nov. 28, 2012.
Written Opinion for Application No. PCT/US2008/002636 dated Jul. 2, 2008.
International Preliminary Report on Patentability for Application No. PCT/US2008/002636 dated Sep. 11, 2009.
International Search Report and Written Opinion for Application No. PCT/US2008/055000 dated Aug. 1, 2008.
International Preliminary Report on Patentability for Application No. PCT/US2008/055000 dated Sep. 11, 2009.
Invitation to Pay Additional Fees for Application No. PCT/US2008/055168 dated Aug. 5, 2008.
International Search Report and Written Opinion for Application No. PCT/US2008/055168 dated Nov. 10, 2008.
International Preliminary Report on Patentability for Application No. PCT/US2008/055168 dated Sep. 11, 2009.
International Search Report and Written Opinion for Application No. PCT/US2008/055136 dated Jul. 24, 2008.
International Preliminary Report on Patentability for Application No. PCT/US2008/055136 dated Sep. 11, 2009.
Invitation to Pay Additional Fees for Application No. PCT/US2009/004866 dated Nov. 27, 2009.
International Search Report and Written Opinion for Application No. PCT/US2009/004866 dated Jan. 27, 2010.
International Preliminary Report on Patentability for Application No. PCT/US2009/004866 dated Mar. 10, 2011.
Invitation to Pay Additional Fees for Application No. PCT/US2009/004877 dated Dec. 8, 2009.
International Search Report and Written Opinion for Application No. PCT/US2009/004877 dated Feb. 12, 2010.
International Preliminary Report on Patentability for Application No. PCT/US2009/004877 dated Mar. 10, 2011.
Office Action for JP Application No. 2009-505495 filed Apr. 13, 2007, unpublished as of Aug. 3, 2012, which Office Action is dated May 8, 2012, and claims as pending for JP Application No. 2009-505495 as of May 8, 2012.
Written Opinion for Application No. PCT/US2007/009107 dated Aug. 17, 2007.
International Preliminary Report on Patentability for Application No. PCT/US2007/009107 dated Oct. 23, 2008.
Partial European Search Report for EP Application No. 11150584.8 filed Oct. 10, 2008, published as EP 2319551 on May 11, 2011, which Search Report is dated Mar. 30, 2011, and claims as pending for EP Application No. 11150584.8 as of Mar. 30, 2011.
Extended European Search Report for EP Application No. 11150584.8 dated Oct. 10, 2008, published as EP 2319551 on May 11, 2011, which Search Report is dated Jul. 26, 2011, and claims as pending for EP Application No. 11150584.8 as of Jul. 26, 2011.
International Search Report and Written Opinion for Application No. PCT/US2008/011663 dated Feb. 20, 2009.
International Preliminary Report on Patentability for Application No. PCT/US2008/011663 dated Apr. 22, 2010.
Invitation to Pay Additional Fees for Application No. PCT/US2009/000433 dated Jun. 4, 2009.
International Search Report and Written Opinion for Application No. PCT/US2009/000433 dated Sep. 25, 2009.
International Preliminary Report on Patentability for Application No. PCT/US2009/000433 dated Aug. 5, 2010.
International Search Report and Written Opinion for Application No. PCT/US2008/055021 dated Jul. 23, 2008.
International Preliminary Report on Patentability for Application No. PCT/US2008/055021 dated Sep. 11, 2009.
Response to Communication dated Jun. 6, 2012 for EP Application No. 10795810.0 filed Oct. 29, 2010, which Response is dated Dec. 14, 2012, and claims as pending for EP Application No. 10795810.0 as of Dec. 14, 2012.
International Search Report and Written Opinion for International Application No. PCT/US2010/054772 dated May 9, 2011.
International Preliminary Report on Patentability for International Application No. PCT/US2010/054772 dated May 1, 2012.
Invitation to Pay Additional Fees for PCT/US2011/043196 dated Nov. 7, 2011.
International Search Report and Written Opinion for PCT/US2011/043196 dated Feb. 17, 2012.
Invitation to Pay Additional Fees for PCT Application No. PCT/US2012/039369 filed May 24, 2012, which Invitation to Pay Additional Fees is dated Sep. 27, 2012, and claims as pending for PCT Application No. PCT/US2012/039369 as of Sep. 27, 2012.
Communication pursuant to Rules 161(1) and 162 EPC for EP Application No. 10795810.0 filed Oct. 29, 2010, published as EP 2493526 on Sep. 5, 2012, which Communication is dated Jun. 6, 2012, and claims as pending for EP Application No. 10795810.0 as of Jun. 6, 2012.
International Preliminary Report on Patentability for PCT/US2011/043196 dated Jan. 17, 2013.
Office Action for U.S. Appl. No. 13/178,191, filed Jul. 7, 2011, published as US 2012-0123322 on May 17, 2012, which Office Action is dated Apr. 5, 2013, and claims as pending for U.S. Appl. No. 13/178,191 as of Apr. 5, 2013.
Office Action for MX Application No. MX/A/2012/005088 filed Oct. 29, 2010, unpublished as of May 13, 2014, which Office Action is dated May 13, 2014, and claims as pending for MX Application No. MX/A/2012/005088 as of May 13, 2014.
Office Action for CN Application No. 201080060563.X filed Jun. 29, 2012, published as CN 102821798 on Dec. 12, 2012, which Office Action is dated Jul. 17, 2014, and claims as pending for CN Application No. 201080060563.X as of Jul. 17, 2014.
Office Action for EP Application No. 10795810.0 filed May 21, 2012, published as EP 2 493 526 on Sep. 5, 2012, which Office Action is dated Aug. 22, 2014, and claims as pending for EP Application No. 10795810.0 as of Aug. 22, 2014.
Office Action for JP Application No. 2012-537127 filed Apr. 27, 2012, unpublished as of Sep. 15, 2014, which Office Action is dated Aug. 19, 2014, and claims as pending for JP Application No. 2012-537127 as of Aug. 19, 2014.
Office Action for MX Application No. MX/A/2012/005088 filed Apr. 30, 2012, unpublished as of Sep. 19, 2014, which Office Action is dated Sep. 19, 2014, and claims as pending for MX Application No. MX/A/2012/005088 as of Sep. 19, 2014.
Office Action for U.S. Appl. No. 12/916,021 filed Oct. 29, 2010, published as US 2011-0105877 on May 5, 2011, which Office Action is dated Jun. 19, 2013, and claims as pending for U.S. Appl. No. 12/916,021 as of Jun. 19, 2013.
Office Action for U.S. Appl. No. 12/916,021 filed Oct. 29, 2010, published as US 2011-0105877 on May 5, 2011, which Office Action is dated Apr. 23, 2014, and claims as pending for U.S. Appl. No. 12/916,021 as of Apr. 23, 2014.
Bengtsson et al., Haemo dialysis software architecture design experiences. Proceedings of the 1999 International Conference on Software Engineering. ACM New York, NY. 1999:516-525.
Choppy et al., Architectural patterns for problem frames. IEE Proceedings: Software. Aug. 2005;152(4): 190-208.
Gentilini et al., Multitasked closed-loop control in anesthesia. IEEE Eng Med Biol Mag. Jan.-Feb. 2001;20(1):39-53.
Harel, Statecharts: A visual formalism for complex systems. Science of Computer Programming. 1987;8:231-274.
Krasner et al., A cookbook for using the model-view-controller user interface paradigm in smalltalk-80. JOOP. Aug. 1988;1(3):26-49.
Office Action for CN Application No. 201510155519.1 filed Apr. 2, 2015, published as CN 104841030A on Aug. 19, 2015, which Office Action is dated Sep. 5, 2016, and claims as pending for CN Application No. 2015101555191 as of Sep. 5, 2016.
U.S. Appl. No. 15/960,426, filed Apr. 23, 2018, Grant et al.
U.S. Appl. No. 15/996,247, filed Jun. 1, 2018, Grant et al.
U.S. Appl. No. 16/011,294, filed Jun. 18, 2018, Van der Merwe et al.
Related Publications (1)
Number Date Country
20150042366 A1 Feb 2015 US
Provisional Applications (1)
Number Date Country
61256735 Oct 2009 US
Continuations (1)
Number Date Country
Parent 12916021 Oct 2010 US
Child 14521654 US